Secondary Recommendation

Warpaint - Strong debut from supplier of affordable colour cosmetics

March 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in Warpaint have enjoyed a terrific run following their introduction to AIM at 97p last November in a float that raised £2.5m for the company and £21m for selling shareholders. The company sells value-for-money colour cosmetics such as eye products and face make-up and has plugged into the bargain hunting zeitgeist dominating our times. For example, its “Hollywood” Bronze and Glow make-up line, priced at £4.99, is almost identical to up-market rival Charlotte Tilbury’s “Film Star” Bronze & Glow, which costs £49. The group boasts a terrific record with revenues almost doubling from £8.6m to £16.8m while EBITDA is up £1m to £5.5m in the two years ended ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Homeserve - Supplier of home assistance policies spots tremendous US opportunity

Sanne - Fund administration outsourcer benefits from post Madoff compliance boom

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X